Results 241 to 250 of about 19,190 (266)

Engineering Oncogenic Hotspot Mutations on SF3B1 via CRISPR-Directed PRECIS Mutagenesis. [PDF]

Cancer Res Commun
Fernandez MM, Yu L, Jia Q, Wang X, Hart KL, Jia Z, Lin RJ, Wang L.   +7 more
europepmc   +1 more source

Relevance of blast counts for genetic subclassification in MDS. [PDF]

Leukemia
Huber S, Haferlach T, Hutter S, Hoermann G, Kern W, Haferlach C.   +5 more
europepmc   +1 more source

FISH mapping in Xenopus pygmaeus refines understanding of genomic rearrangements and reveals jumping NORs in African clawed frogs. [PDF]

Heredity (Edinb)
Bergelová B, Gvoždík V, Knytl M.
europepmc   +1 more source

Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1-risk MDS. [PDF]

Blood Adv
Cannova J, Madero-Marroquin R, Odenike O.   +2 more
europepmc   +1 more source

Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T_reg function via aberrant Anapc13 splicing. [PDF]

Sci Adv
Shi Y, Zhang W, Jia Q, Zhong X, Iyer P, Wu H, Yuan YC, Zhao Y, Zhang L, Wang L, Jia Z, Kuo YH, Sun Z.   +12 more
europepmc   +1 more source

The apoptosis geneBCL-Xsplice isoforms have opposing effects in diabetic kidney disease: potential treatment target and prognostic value

Stevens M, Ayine ML, Gooding K, Shore A, Marqueti P, Oltean S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Significance of SF3B1 Mutations in Myeloid Neoplasms

Clinics in Laboratory Medicine, 2023
Myelodysplastic neoplasm with low blasts and SF3B1 mutation (MDS-LB-SF3B1) has undergone significant classification changes in the past year with the publication of the 5th edition of the World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues and the International Consensus Classification.
David C, Gajzer, Cecilia C S, Yeung
openaire   +2 more sources

Role Of Sf3b1 On Hematopoiesis

Blood, 2013
Abstract Frequent pathway mutation involving multiple components of the RNA splicing machinery is a cardinal feature of myeloid neoplasms showing myeloid dysplasia, in which the major mutational targets include U2AF35, ZRSR2, SRSF2 and SF3B1.
Makoto Otsu, Aiko Sato, Ayana Kon, Masashi Sanada, Yasunobu Nagata, Kenichi Yoshida, Haruhiko Koseki, Seishi Ogawa, Hiromitsu Nakauchi, Ryo Yamamoto, Tetsuichi Yoshizato, Yusuke Shiozawa, Manabu Matsunawa, Kyoichi Isono   +13 more
openaire   +2 more sources

SF3B1in Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2012
To the Editor: Wang et al. (Dec. 29 issue)1 report that SF3B1 mutation is associated with a shorter time to initiation of treatment in patients with chronic lymphocytic leukemia. However, this result should be interpreted with caution. In the discovery cohort of 91 patients, 29 were classified as having stage 0 disease, 43 as having stage I, and 19 as ...
Jinichi Mori, Yukie Takahashi, Tetsuya Tanimoto   +2 more
openaire   +3 more sources

Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.

European Journal of Endocrinology, 2023
OBJECTIVE A somatic mutational hotspot in the SF3B1 gene was reported in lactotroph tumours. The aim of our study was to examine the prevalence of driver SF3B1 variants in a multicentre independent cohort of patients with lactotroph tumours and correlate
J. Simon, L. Perez-Rivas, Yining Zhao, Fanny Chasseloup, H. Lasolle, C. Cortet, Françoise Descotes, Chiara Villa, B. Baussart, P. Burman, Dominique Maiter, Vivian von Selzam, R. Rotermund, J. Flitsch, Jun Thorsteinsdottir, E. Jouanneau, Michael Buchfelder, Philippe Chanson, G. Raverot, M. Theodoropoulou   +19 more
semanticscholar   +1 more source